| 1 | 1316878 | Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. | Infect Immun | 1992 Jun |
2 |
| 2 | 7763011 | Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin. | Anticancer Res | 1995 Mar-Apr |
1 |
| 3 | 8689632 | Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells. | Cancer Lett | 1996 Jul 19 |
1 |
| 4 | 8895738 | The role of DNA mismatch repair in platinum drug resistance. | Cancer Res | 1996 Nov 1 |
1 |
| 5 | 9114434 | Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line. | Oncol Res | 1996 |
6 |
| 6 | 9220289 | Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines. | Invest New Drugs | 1997 |
1 |
| 7 | 9488590 | Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. | Cancer Epidemiol Biomarkers Prev | 1998 Feb |
2 |
| 8 | 9721864 | The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. | Cancer Res | 1998 Aug 15 |
2 |
| 9 | 9752993 | Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers. | Cancer Epidemiol Biomarkers Prev | 1998 Sep |
1 |
| 10 | 9804612 | Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. | Mol Pharmacol | 1998 Nov |
3 |
| 11 | 9804920 | Cytogenetic biomonitoring of workers exposed to bitumen fumes. | Mutat Res | 1998 Nov 9 |
1 |
| 12 | 10098743 | Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. | Br J Cancer | 1999 Mar |
2 |
| 13 | 10098901 | Biotransformations of oxaliplatin in rat blood in vitro. | J Biochem Mol Toxicol | 1999 |
1 |
| 14 | 10367745 | Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats. | Cancer Chemother Pharmacol | 1999 |
1 |
| 15 | 10460158 | Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. | Biochemistry | 1999 Aug 24 |
2 |
| 16 | 10511262 | Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. | Toxicol Lett | 1999 Sep 5 |
3 |
| 17 | 10606258 | Oxaliplatin: a new therapeutic option in colorectal cancer. | Semin Oncol | 1999 Dec |
1 |
| 18 | 10626357 | Specificity of platinum-DNA adduct repair. | J Inorg Biochem | 1999 Oct |
2 |
| 19 | 10650914 | The influence of cytochrome P450 1A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers. | Arch Toxicol | 1999 Nov |
1 |
| 20 | 10753202 | CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. | Carcinogenesis | 2000 Apr |
2 |
| 21 | 10769112 | Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. | Biochemistry | 2000 Apr 25 |
2 |
| 22 | 10777605 | The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta. | J Biol Chem | 2000 Apr 28 |
3 |
| 23 | 11053984 | Oxaliplatin-induced fever and release of IL-6. | Oncology | 2000 Sep |
3 |
| 24 | 11142694 | Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cisplatin and carboplatin. | Anticancer Drugs | 2000 Nov |
1 |
| 25 | 11167991 | Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression. | Clin Exp Immunol | 2001 Jan |
1 |
| 26 | 11323399 | Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. | Carcinogenesis | 2001 May |
3 |
| 27 | 11583787 | Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry. | J Inorg Biochem | 2001 Oct |
1 |
| 28 | 11593056 | Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo. | Anticancer Drugs | 2001 Oct |
1 |
| 29 | 11600727 | Urinary 1-hydroxypyrene in coke oven workers relative to exposure, alcohol consumption, and metabolic enzymes. | Occup Environ Med | 2001 Nov |
4 |
| 30 | 11705873 | Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies. | Clin Cancer Res | 2001 Nov |
1 |
| 31 | 11712813 | A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. | Anticancer Res | 2001 Jul-Aug |
1 |
| 32 | 11731512 | ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. | J Clin Oncol | 2001 Dec 1 |
3 |
| 33 | 11824623 | Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5'-GMP in the presence of the sulfur-containing amino acid L-methionine. | Electrophoresis | 2002 Jan |
7 |
| 34 | 11859435 | The effect of relevant genotypes on PAH exposure-related biomarkers. | J Expo Anal Environ Epidemiol | 2002 Jan-Feb |
1 |
| 35 | 11919232 | Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. | J Clin Oncol | 2002 Apr 1 |
1 |
| 36 | 11953866 | Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity. | Br J Cancer | 2002 Apr 8 |
1 |
| 37 | 11958906 | Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. | Int J Radiat Oncol Biol Phys | 2002 Mar 15 |
1 |
| 38 | 12008204 | Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death. | Eur J Cancer | 2002 May |
2 |
| 39 | 12072547 | Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. | J Natl Cancer Inst | 2002 Jun 19 |
2 |
| 40 | 12144121 | Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients. | J Biol Regul Homeost Agents | 2002 Apr-Jun |
2 |
| 41 | 12372606 | Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma. | FEBS Lett | 2002 Oct 9 |
1 |
| 42 | 12391279 | The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. | Mol Pharmacol | 2002 Nov |
1 |
| 43 | 12434296 | Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2. | Br J Cancer | 2002 Oct 21 |
1 |
| 44 | 12441268 | Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin. | Eur J Cancer | 2002 Nov |
1 |
| 45 | 12499281 | Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. | Cancer Res | 2002 Dec 15 |
2 |
| 46 | 12504667 | Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines. | Eur J Cancer | 2003 Jan |
6 |
| 47 | 12531010 | Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta. | DNA Repair (Amst) | 2002 Dec 5 |
7 |
| 48 | 12553056 | Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat. | Anticancer Res | 2002 Nov-Dec |
3 |
| 49 | 12570658 | Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair. | Curr Cancer Drug Targets | 2003 Feb |
1 |
| 50 | 12578393 | Translesion synthesis past platinum DNA adducts by human DNA polymerase mu. | Biochemistry | 2003 Feb 18 |
1 |